203 related articles for article (PubMed ID: 26893685)
1. Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study.
Hafsi S; Candido S; Maestro R; Falzone L; Soua Z; Bonavida B; Spandidos DA; Libra M
Oncol Lett; 2016 Feb; 11(2):1021-1025. PubMed ID: 26893685
[TBL] [Abstract][Full Text] [Related]
2. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.
Castellano G; Torrisi E; Ligresti G; Nicoletti F; Malaponte G; Traval S; McCubrey JA; Canevari S; Libra M
Cell Cycle; 2010 Feb; 9(3):557-63. PubMed ID: 20081364
[TBL] [Abstract][Full Text] [Related]
3. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas.
Thapa DR; Li X; Jamieson BD; Martínez-Maza O
PLoS One; 2011; 6(6):e20781. PubMed ID: 21698185
[TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0001925 promotes malignant progression in triple-negative breast cancer via miR-1299/YY1 axis.
Shen BJ; Yang YF; Zhang XX
Thorac Cancer; 2023 Mar; 14(8):746-757. PubMed ID: 36754085
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-21 and microRNA-155 promote the progression of Burkitt's lymphoma by the PI3K/AKT signaling pathway.
Han B; Wang S; Zhao H
Int J Clin Exp Pathol; 2020; 13(1):89-98. PubMed ID: 32055277
[TBL] [Abstract][Full Text] [Related]
7. Suitability of Yin Yang 1 transcript and protein levels for biomarker studies in B cell non-Hodgkin lymphoma.
Arribas Arranz J; Winter DN; Drexler HG; Eberth S
Biomark Res; 2018; 6():11. PubMed ID: 29564133
[TBL] [Abstract][Full Text] [Related]
8. miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1- facilitated MMP-14 expression.
Zheng L; Chen Y; Ye L; Jiao W; Song H; Mei H; Li D; Yang F; Li H; Huang K; Tong Q
Sci Rep; 2017 Aug; 7(1):8967. PubMed ID: 28827574
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional factor Yin Yang 1 facilitates the stemness of ovarian cancer via suppressing miR-99a activity through enhancing its deacetylation level.
Qian S; Wang W; Li M
Biomed Pharmacother; 2020 Jun; 126():110085. PubMed ID: 32199224
[TBL] [Abstract][Full Text] [Related]
10. The Yin and Yang of YY1 in tumor growth and suppression.
Khachigian LM
Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
[TBL] [Abstract][Full Text] [Related]
11. miR-532-5p Inhibits Non-Small Cell Lung Cancer Progression In Vivo and In Vitro by Targeting Yin Yang 1.
Li S; Zhu C; Wang Q; Wen Y
Crit Rev Eukaryot Gene Expr; 2022; 32(5):47-61. PubMed ID: 35993944
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
13. Modulation of MicroRNA Cluster miR-183-96-182 Expression by Epstein-Barr Virus Latent Membrane Protein 1.
Oussaief L; Fendri A; Chane-Woon-Ming B; Poirey R; Delecluse HJ; Joab I; Pfeffer S
J Virol; 2015 Dec; 89(23):12178-88. PubMed ID: 26401047
[TBL] [Abstract][Full Text] [Related]
14. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
15. A Novel YY1-miR-1 regulatory circuit in skeletal myogenesis revealed by genome-wide prediction of YY1-miRNA network.
Lu L; Zhou L; Chen EZ; Sun K; Jiang P; Wang L; Su X; Sun H; Wang H
PLoS One; 2012; 7(2):e27596. PubMed ID: 22319554
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of miRNAs in esophageal cancer tissue.
Liu SG; Qin XG; Zhao BS; Qi B; Yao WJ; Wang TY; Li HC; Wu XN
Oncol Lett; 2013 May; 5(5):1639-1642. PubMed ID: 23761828
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
[TBL] [Abstract][Full Text] [Related]
18. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
Yang Y; Mei Q
Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
[TBL] [Abstract][Full Text] [Related]
19. Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma.
Oduor CI; Kaymaz Y; Chelimo K; Otieno JA; Ong'echa JM; Moormann AM; Bailey JA
BMC Cancer; 2017 Nov; 17(1):761. PubMed ID: 29132323
[TBL] [Abstract][Full Text] [Related]
20. Unique MicroRNAs Signature of Lymphocyte of Yang and Yin Syndromes in Acute Ischemic Stroke Patients.
Zhao HP; Liu P; Xu CM; Li GW; Gao L; Luo YM
Chin J Integr Med; 2019 Aug; 25(8):590-597. PubMed ID: 29926387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
